September 30, 2013 BioRestorative Therapies Inc. , a life sciences company focused on developing stem cell-based therapies for personal medical applications, announced the engagement of the regulatory consultancy firm Phil Triolo and Associates, LC to help advance the Company's brtxDISC therapeutic procedure through the U.S. Food and Drug ... (more)
http://www.investorideas.com/CO/BRTX/news/2013/09301.asp
http://www.investorideas.com/CO/BRTX/news/2013/09301.asp
No comments:
Post a Comment